These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30798007)

  • 1. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
    Melero-Jerez C; Suardíaz M; Lebrón-Galán R; Marín-Bañasco C; Oliver-Martos B; Machín-Díaz I; Fernández Ó; de Castro F; Clemente D
    Neurobiol Dis; 2019 Jul; 127():13-31. PubMed ID: 30798007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation.
    Melero-Jerez C; Fernández-Gómez B; Lebrón-Galán R; Ortega MC; Sánchez-de Lara I; Ojalvo AC; Clemente D; de Castro F
    Glia; 2021 Apr; 69(4):905-924. PubMed ID: 33217041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
    Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
    Melero-Jerez C; Alonso-Gómez A; Moñivas E; Lebrón-Galán R; Machín-Díaz I; de Castro F; Clemente D
    Neurobiol Dis; 2020 Jul; 140():104869. PubMed ID: 32278882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
    Jiang Q; Duan J; Van Kaer L; Yang G
    Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells.
    Wang JL; Li B; Tan GJ; Gai XL; Xing JN; Wang JQ; Quan MY; Zhang N; Guo L
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32301489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
    Moliné-Velázquez V; Cuervo H; Vila-Del Sol V; Ortega MC; Clemente D; de Castro F
    Brain Pathol; 2011 Nov; 21(6):678-91. PubMed ID: 21507122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151.
    Zhang B; Harness J; Somodevilla-Torres MJ; Hillyard NC; Mould AW; Alewood D; Love SG; Alewood PF; Greer JM; Cavanagh AC; McCombe PA; Morton H
    J Neurol Sci; 2000 Dec; 182(1):5-15. PubMed ID: 11102634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.
    Sweeney CM; Lonergan R; Basdeo SA; Kinsella K; Dungan LS; Higgins SC; Kelly PJ; Costelloe L; Tubridy N; Mills KH; Fletcher JM
    Brain Behav Immun; 2011 Aug; 25(6):1170-81. PubMed ID: 21420486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
    Ortega MC; Lebrón-Galán R; Machín-Díaz I; Naughton M; Pérez-Molina I; García-Arocha J; Garcia-Dominguez JM; Goicoechea-Briceño H; Vila-Del Sol V; Quintanero-Casero V; García-Montero R; Galán V; Calahorra L; Camacho-Toledano C; Martínez-Ginés ML; Fitzgerald DC; Clemente D
    Acta Neuropathol; 2023 Aug; 146(2):263-282. PubMed ID: 37243699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis.
    Camacho-Toledano C; Machín-Díaz I; Lebrón-Galán R; González-Mayorga A; Palomares FJ; Serrano MC; Clemente D
    Nanoscale; 2024 Apr; 16(15):7515-7531. PubMed ID: 38498071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
    Wegner A; Verhagen J; Wraith DC
    Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
    Camacho-Toledano C; Machín-Díaz I; Calahorra L; Cabañas-Cotillas M; Otaegui D; Castillo-Triviño T; Villar LM; Costa-Frossard L; Comabella M; Midaglia L; García-Domínguez JM; García-Arocha J; Ortega MC; Clemente D
    J Neuroinflammation; 2022 Nov; 19(1):277. PubMed ID: 36403026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
    Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
    Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.
    Tanwar S; Oguz C; Metidji A; Dahlstrom E; Barbian K; Kanakabandi K; Sykora L; Shevach EM
    J Autoimmun; 2020 Dec; 115():102525. PubMed ID: 32709481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
    Axtell RC; de Jong BA; Boniface K; van der Voort LF; Bhat R; De Sarno P; Naves R; Han M; Zhong F; Castellanos JG; Mair R; Christakos A; Kolkowitz I; Katz L; Killestein J; Polman CH; de Waal Malefyt R; Steinman L; Raman C
    Nat Med; 2010 Apr; 16(4):406-12. PubMed ID: 20348925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.